share_log

方盛制药(603998.SH):全资子公司被认定为高新技术企业

Hunan Fangsheng Pharmaceutical (603998.SH): A wholly-owned subsidiary has been recognized as a high-tech enterprise.

Gelonghui Finance ·  Dec 17 16:02

On December 17, Gelonghui reported that Hunan Fangsheng Pharmaceutical (603998.SH) announced that on December 17, 2024, the Office of the Leading Group for the Management of National High-tech Enterprise Certification issued the "Notice on the Filing of the Second Batch of High-tech Enterprises Recognized by Institutions in Guangdong Province for 2024." The company's wholly-owned subsidiary, Guangdong Fangsheng Jianmeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Fangsheng Jianmeng"), has been recognized as a high-tech enterprise, with certificate number GR202444006126, issued on November 28, 2024, and is valid for three years. The recognition of Fangsheng Jianmeng as a high-tech enterprise will further enhance its innovation capabilities and strengthen its market competitiveness.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment